Gene Expression Profile of Acute Myeloid Leukemia (AML) with t(8;16)(p11;p13) and MYST3/CREBBP Rearrangement.

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 2054-2054
Author(s):  
Mireia Camos ◽  
Jordi Esteve ◽  
Pedro Jares ◽  
Maria Rozman ◽  
Dolors Colomer ◽  
...  

Abstract Translocation t(8;16)(p11;p13) is an infrequent chromosomal abnormality in de novo and secondary AML cases, leading to the fusion of MYST3 (MOZ) and CREBBP (CBP) genes, both of them harboring histone lysine acetyl-transferase activity. This AML variety displays specific clinical and biological features, although its gene expression profile is currently unknown. In this study, the genetic signature of AML cases with MYST3/CREBBP rearrangement was compared with the genetic profile of other well-defined AML subtypes. Genotypic analyses using oligonucleotide U133A arrays (Affymetrix) were performed on RNA of 19 AML samples, including t(8;16)-AML (n=3), t(15;17) (n=3), t(8;21) (n=2), inv(16)/t(16;16) (n=3), t(9;11) with AF9/MLL rearrangement (n=2), 3 cases with normal karyotype and flt-3 internal tandem duplication (flt-3 ITD), the three remaining samples corresponding to monocytic cases (M4/M5) without MLL rearrangement nor flt-3 ITD. After unsupervised analysis, cases of AML with t(8;16) clustered together, displaying a differential expression profile. Supervised analysis allowed the identification of the top 53 up-regulated and 28 down-regulated genes. Among the set of genes overexpressed, genes involved in chromatin remodelling and transcription (HOXA9, HOXA10, MEIS1, CHD3, SATB1) and protooncogenes (RET, flt-3, LMO2) were identified. In contrast, CREBBP gene and several members of the JAK-STAT pathway (STAT3, STAT5B, JAK2) were underexpressed. Interestingly, overexpression of multiple homeobox genes was detected in flt-3 ITD cases, some of them as a distinctive finding (HOXA2, HOXA3, HOXB6), and others (HOXA9, HOXA10, MEIS1) were found to be highly expressed in MYST3/CREBBP and MLL-rearranged samples. In conclusion, AML with t(8;16) and MYST3/CREBBP rearrangement shows a distinctive gene expression profile, with some similarities with MLL rearranged leukemias and flt-3 ITD AML cases, thus suggesting a partially common leukemogenic pathway.

Toxicology ◽  
2007 ◽  
Vol 231 (2-3) ◽  
pp. 200-209 ◽  
Author(s):  
M TOMITA ◽  
T OKUYAMA ◽  
H KATSUYAMA ◽  
Y MIURA ◽  
Y NISHIMURA ◽  
...  

2019 ◽  
Author(s):  
Roman U. Goz ◽  
Ari Silas ◽  
Sara Buzel ◽  
Joseph J. LoTurco

AbstractBACKGROUNDFrequent de-novo somatic mutations in major components (PI3KCA, AKT3, TSC1, TSC2, mTOR, BRAF) of molecular pathways crucial for cell differentiation, proliferation, growth and migration (mTOR, MAPK) has been previously implicated in malformations of cortical development (MCDs) and low-grade neuroepithelial tumors (LNETs) 1–7. LNETs are the most frequent tumors found in patients undergoing resective surgery for refractory epilepsy treatment. BRAFV600E is found in up to 70% of LNETs. Previous studies suggest a causal relationship between those de-novo somatic mutations in mTOR, MAPK pathways and seizures occurrence, even without presence of malformation or a tumor 2, 3, 8–13. Recently Koh and colleagues 14 showed that BRAFV600E mutation may cause seizures through activation of RE1-silecing transcription factor (REST). Additionally, they showed a significant downregulation of synaptic transmission and plasticity pathways and decreased expression of multiple ion channels subunits including HCN1, KCNQ3, SCN2A and SCN3B. The downregulation of those genes including GABA receptors subunits and protein expression specific to interneurons subpopulations (SST, VIP) suggests that a dysregulated inhibitory circuits are responsible for seizures in GGs. The experimental manipulation - In-Utero electroporation of episomal activating Cre plasmids that they used to test their hypothesis in mice however activated mutant BRAFV637 only in excitatory neurons. And the downregulated genes in mice were confirmed by qRT-PCR in the whole tissue samples. The question of how electrophysiological properties of the affected and surrounding neurons are changed were not addressed. The changes in ion conductances and neuronal circuits responsible for seizures could be only inferred from gene expression profiles. Purpose of the current work was to investigate how overactive human BRAFV600E mutated protein incorporated into the mouse genome through piggyBase transposition increase neuronal excitability in ex-vivo mouse cortical slices and whether it induces histopathological features and gene expression profile alteration observed in low-grade neuroepithelial tumors (LNETs).METHODSUsing In-Utero Electroporation we have introduced human BRAFV600E protein into radial glia progenitors in mouse embryonic cortex on the background of piggyBac transposon system that allows incorporation of the DNA sequence of interest into the genome. Immunohistochemistry was used for examination of known markers in LNETs. RNA sequencing on Illumina NextSeq 500 was used to examine alterations in gene expression profiles. Whole-cell current- and voltage-clamp was used to examine changes in electrophysiological properties. Unsupervised Hierarchical Clustering Analysis was used to examine grouping of different conditions based on their gene expression profile and electrophysiological properties. Video electrocorticographic recordings were used to test whether BRAFV600E transgenic mice have spontaneous seizures.RESULTSUnder GLAST driving promoter BRAFV600E induced astrogenesis, caused morphological alterations in transgenic cells akin to balloon-like cells, and delayed neuronal migration. Under NESTIN driver promoter BRAFV600E increased neurogenesis, induced balloon-like cells and caused some cells to remain close to the lateral ventricle displaying large soma size compared to neurons in the upper cortical layers. Some of the balloon-like cells were immunopositive for astroglial marker glial fibrillary acidic protein (GFAP), and for both upper and lower cortical layers markers (Cux1 and Ctip2). Gene ontology analysis for BRAFV600E gene expression profile showed that there is a tissue-wide increased inflammatory immune response, complement pathway activation, microglia recruitment and astrocytes activation, which supported increased immunoreactivity to microglial marker iba1, and to GFAP respectively. In current clamp BRAFV600E neurons have increased excitability properties including more depolarized resting membrane potential, increased input resistance, low capacitance, low rheobase, low action potential (AP) voltage threshold, and increased AP firing frequency. Additionally, BRAFV600E neurons have increased SAG and rebound excitation, indicative of increased hyperpolarization activated depolarizing conductance (IH), which is confirmed in voltage-clamp. The sustained potassium current sensitive to tetraethylammonium was decreased in BRAFV600E neurons.. In 4 out of 59 cells, we have also observed a post-action potential depolarizing waves, frequencies of which increased in potassium current recording when Ca2+ was substituted to Co2+ in the extracellular solution (5/24). We show that using 20 electrophysiological properties BRAFV600E neurons segregate separately from other conditions. Comparison of electrophysiological properties of those neurons with neurons bearing somatic mutations in mechanistic target of rapamycin (MTOR) pathway regulatory components, overactivation of which is been shown in malformations of cortical development (MCDs), showed that expression of PIK3CAE545K under GLAST+ promoter and TSC1 knockdown (KD) with CRISPR-Cas9 have different effects on neuronal excitability.


Blood ◽  
2013 ◽  
Vol 121 (2) ◽  
pp. 385-391 ◽  
Author(s):  
Sebastian Schwind ◽  
Colin G. Edwards ◽  
Deedra Nicolet ◽  
Krzysztof Mrózek ◽  
Kati Maharry ◽  
...  

Abstract The inv(16)(p13q22)/t(16;16)(p13;q22) in acute myeloid leukemia results in multiple CBFB-MYH11 fusion transcripts, with type A being most frequent. The biologic and prognostic implications of different fusions are unclear. We analyzed CBFB-MYH11 fusion types in 208 inv(16)/t(16;16) patients with de novo disease, and compared clinical and cytogenetic features and the KIT mutation status between type A (n = 182; 87%) and non–type A (n = 26; 13%) patients. At diagnosis, non–type A patients had lower white blood counts (P = .007), and more often trisomies of chromosomes 8 (P = .01) and 21 (P < .001) and less often trisomy 22 (P = .02). No patient with non–type A fusion carried a KIT mutation, whereas 27% of type A patients did (P = .002). Among the latter, KIT mutations conferred adverse prognosis; clinical outcomes of non–type A and type A patients with wild-type KIT were similar. We also derived a fusion-type–associated global gene-expression profile. Gene Ontology analysis of the differentially expressed genes revealed—among others—an enrichment of up-regulated genes involved in activation of caspase activity, cell differentiation and cell cycle control in non–type A patients. We conclude that non–type A fusions associate with distinctclinical and genetic features, including lack of KIT mutations, and a unique gene-expression profile.


Reproduction ◽  
2013 ◽  
Vol 145 (1) ◽  
pp. 85-96 ◽  
Author(s):  
M Endo ◽  
R Kawahara-Miki ◽  
F Cao ◽  
K Kimura ◽  
T Kuwayama ◽  
...  

Antrum formation and estradiol (E2) secretion are specific features of oocyte and granulosa cell complexes (OGCs). This study investigates the effect of E2 on the in vitro development of bovine OGCs derived from early antral follicles as well as on the expression of genes in granulosa cells (GCs). The supplementation of culture medium with either E2 or androstenedione (A4) improved the in vitro development of OGCs and the nuclear maturation of enclosed oocytes. When OGCs were cultured in medium containing A4, developmentally competent OGCs secreted more E2 than OGCs that were not competent. In addition, fulvestrant inhibited the effect of both E2 and A4 on OGCs development. Comprehensive gene expression analysis using next-generation sequence technology was conducted for the following three types of GCs: i) GCs of OGCs cultured for 4 days with E2 (1 μg/ml; E2(+)), ii) GCs of OGCs cultured for 4 days without E2 (E2(−)) or iii) OGCs that formed clear antrum after 8 days of in vitro culture in medium containing E2 (1 μg/ml; AF group). GCs of the E2(+) group had a similar gene expression profile to the profile reported previously for the in vivo development of large follicles. This genetic profile included factors implicated in the up-regulation of E2 biosynthesis and down-regulation of cytoskeleton and extracellular matrices. In addition, a novel gene expression profile was found in the AF group. In conclusion, E2 impacts the gene expression profile of GCs to support the in vitro development of OGCs.


BMC Genomics ◽  
2017 ◽  
Vol 18 (1) ◽  
Author(s):  
Monika Frazier ◽  
Martin Helmkampf ◽  
M. Renee Bellinger ◽  
Scott M. Geib ◽  
Misaki Takabayashi

2009 ◽  
Author(s):  
Rachel Yehuda ◽  
Julia Golier ◽  
Sandro Galea ◽  
Marcus Ising ◽  
Florian Holsborer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document